• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (MEDFORD) SERI SURGICAL SCAFFOLD (US); MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY Back to Search Results
Catalog Number SCF10X25AGEN
Device Problems Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993); Appropriate Term/Code Not Available (3191)
Patient Problems Wound Dehiscence (1154); Abscess (1690); Pain (1994); Fluid Discharge (2686)
Event Date 11/16/2015
Event Type  Injury  
Manufacturer Narrative
Medwatch sent to fda on 3/30/2016.The device has not been returned.Therefore, no analysis or testing has been done.These events are being reported because medical intervention was required, although device-relatedness has not been established."fluid discharge" is a physiological complication, and analysis of the device generally does not assist allergan in determining a probable cause for this event.The reporter has declined to provide allergan further information regarding event, product, or patient details.
 
Event Description
Company representative reported that after implant with seri surgical scaffold, the patient developed blisters, pustules with sterile fluid coming out, with "loss of implants".Treatment status is unknown.
 
Manufacturer Narrative
Medwatch sent to fda on 06/16/2016.The events of wound dehiscence, abscess, bleeding, pain, induration, exposure and inadequate tissue ingrowth are physiological complications, and analysis of the device generally does not assist allergan in determining a probable cause for these events.The physician discarded the device when it was explanted and it is no longer available for return.Therefore allergan will not receive it and no analysis or testing will be done.
 
Event Description
Physician reported revision to right side breast reconstruction with seri® surgical scaffold on (b)(6) 2015.Post-implantation, the patient visited the er for bleeding on or before (b)(6) 2015 which resolved.Healing continued normally until (b)(6) 2016 when the patient presented with an opening of the wound in the right breast with redness and tenderness that had begun to drain.Physician prescribed keflex, and identified induration around the wound which was diagnosed as a well contained abscess.This was opened further and completely drained.The symptoms resolved, but by (b)(6) 2016 the redness had returned.On (b)(6) 2016 the patient presented again with drainage from the wound.Physician prescribed continued antibiotics.The wound continued to drain, and by (b)(6) 2016, the patient had developed ¿a couple of boli¿ at the right inframammary crease.These were incised and drained.Physician attributed the events to a reaction to the seri® device at this time.The wound continued to drain until (b)(6) 2016 when physician decided to remove the seri® and breast implant after a ¿silver dollar sized exposure of her implant and the seri® sling¿ developed at the wound site.The symptoms resolved after this.Physician reported that the device showed no integration with the patient tissue when it was removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SERI SURGICAL SCAFFOLD (US)
Type of Device
MESH, SURGICAL, ABSORBABLE, PLASTIC AND RECONSTRUCTIVE SURGERY
Manufacturer (Section D)
ALLERGAN (MEDFORD)
200 boston avenue
medford MA 02155
Manufacturer (Section G)
ALLERGAN (MEDFORD)
200 boston avenue
medford MA 02155
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key5536859
MDR Text Key41511175
Report Number8020862-2016-00026
Device Sequence Number1
Product Code OXF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123128
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/03/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2018
Device Catalogue NumberSCF10X25AGEN
Device Lot NumberP14121201A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/03/2016
Initial Date FDA Received03/30/2016
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/16/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/30/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-